Evidence map›Paper›PMID 42078910›Full record

ArticleResearch square2026

A phosphorylation switch at MRE11 links ATM-ATR and calcium signaling to safeguard stalled replication fork stability.

Weihang Valerie Chai, Manobendro Ray, Chih-Chun Chang, Zhen-Guo Wang, Zhiguo Li, Peter Chi

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Weihang Valerie ChaiRosalind Franklin University of Medicine and Sciences, Chicago Medical School.ORCID https://orcid.org/0000-0003-1206-2324
Manobendro RayRosalind Franklin University of Medicine and Sciences, Chicago Medical School.
Chih-Chun ChangNational Taiwan University.
Zhen-Guo WangRosalind Franklin University of Medicine and Sciences, Chicago Medical School.
Zhiguo LiUniversity of Kentucky.
Peter ChiNational Taiwan University.ORCID https://orcid.org/0000-0001-9229-8729

Funding

Molecular Modulator of RPA and RAD51 in Maintaining Genome StabilityR01CA234266 · NCI · WASHINGTON STATE UNIVERSITY · PI Weihang Chai · 2019 to 2026
$2.4M
Molecular Basis of Coats Plus DiseaseR01GM146376 · NIGMS · ROSALIND FRANKLIN UNIV OF MEDICINE & SCI · PI Weihang Chai · 2023 to 2026
$1.7M
NCI NIH HHS R01 CA234266NIGMS NIH HHS R01 GM146376
6 · The paper itself

Abstract

MRE11 safeguards genome stability at stalled replication forks, where its activity must be tightly controlled to prevent nascent strand DNA degradation (NSD). However, the upstream signaling mechanisms that limit NSD remain poorly defined. Here, we identify Ser649 (S649) as a previously unrecognized phosphorylation site that limits MRE11 association with stalled forks. We show that S649 phosphorylation is robustly induced by replication stress or elevated cytosolic calcium levels, and is mediated by the calcium-responsive CaMKK2-AMPKα axis in concert with ATR, but independently of CHK1. Loss of S649 phosphorylation enhances MRE11 binding to DNA and increases its association with stalled forks, driving excessive NSD, elevated DNA damage, and increased sensitivity to PARP inhibition. We find that the ATM-mediated S676/S678 phosphorylation primes S649 phosphorylation, which in turn facilitates subsequent phosphorylation of SQ/TQ sites in MRE11. Moreover, we find that CaMKK2-AMPKα activation requires ATR but is independent of ATM. Collectively, our findings reveal a hierarchical signaling mechanism that couples calcium signaling with ATM/ATR pathways to prevent NSD at stalled forks and preserve genome integrity.

Identifiers

PMID42078910
PMCPMC13131871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.